Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Royal Wedding In Focus

Published 05/17/2018, 10:38 PM
Updated 07/09/2023, 06:31 AM

With a highly anticipated royal wedding on the docket for this weekend — if you’ve been living under a rock, Prince Harry will be wed to American actress and humanitarian activist Meghan Markle Saturday, mid-day in England and very early in the a.m. U.S. time — we thought it might be worthwhile to take a peek at the performance of British-oriented stocks. Especially now that the Brexit decision voted on nearly 2 years ago is finally being enacted, we may be seeing different forecasts for some of our favorite English stocks.

This is hardly the only article featuring such equities, by the way, even here at Zacks.com. We published a separate study of top-rated British companies earlier this week here: Royal Wedding, Record Job Growth Aid U.K. Economy: 5 Picks

Integrated oil super-major BP (LON:BP) Inc. (NYSE:BP) is clearly not feeling any negative effects from Brexit activity; Brent crude oil prices recently having hit $80 per barrel are assisting this Zacks Rank #1 (Strong Buy) company, with its Zacks Style Score (Value - Growth - Momentum) of A. Its neighbors in the sector are also doing well overall — BP sits in the top 13% of Zacks Industry Rank and top 25% in Sector Rank.

Shares are down slightly in today’s pre-market, but have been steadily climbing back from the fall in oil prices a few years back. That said, BP shares are still off their multi-year highs experienced just prior to the company’s Deepwater Horizon oil spill in the Gulf of Mexico, which was raging at this time 8 years ago. But BP stock is up a couple dollars per share over the past month.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Big Pharma company AstraZeneca (NYSE:AZN) also boasts a Zacks Style Score of A, with a Zacks Rank of #3 (Hold). However, it resides in a sector within the bottom 31% on the Zacks scale. The company is well diversified, but did suffer a setback recently with its asthma treatment Fasenra having failed a COPD study. Shares are down a bit ahead of the opening bell today, but continue to trade in a range just beneath its all-time highs hit just a few years ago.

County Kent’s own Delphi Automotive (NYSE:APTV) , an auto tech specialty company featuring solutions in auto emissions and fuel economy, currently holds a Zacks Rank #2 (Buy). However, its Style Score is D, on relatively lagging Growth and Momentum. But it proudly hails at all-time market highs, even if it closed slightly lower than yesterday’s record high $98.50 per share (U.S.).



AstraZeneca PLC (AZN): Free Stock Analysis Report

BP p.l.c. (BP): Free Stock Analysis Report

Delphi Automotive PLC (APTV): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.